Long term responders in frontline multiple myeloma-exception vs expectation of the modern era
Blood Cancer J
.
2024 Jul 17;14(1):115.
doi: 10.1038/s41408-024-01100-z.
Authors
Muhamed Baljevic
#
1
,
Douglas W Sborov
#
2
,
Shaji K Kumar
#
3
Affiliations
1
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
[email protected]
.
2
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
3
Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA.
#
Contributed equally.
PMID:
39019891
PMCID:
PMC11255324
DOI:
10.1038/s41408-024-01100-z
No abstract available
Publication types
Editorial
MeSH terms
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Female
Humans
Male
Middle Aged
Multiple Myeloma* / therapy
Treatment Outcome